PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CNR-IBF, Istituto di Biofisica, Via Celoria 26, I-20133, Milano, Italy; Dipartimento di Bioscienze, Università di Milano, Via Celoria 26, I-20133, Milano, Italy.\', \'Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Regione Gonzole, 10, I-10043, Orbassano, Turin, Italy.\', \'Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I-34149, Trieste, Italy.\', \'High Throughput Screening Facility of the International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I-34149, Trieste, Italy.\', \'Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I-34149, Trieste, Italy. Electronic address: marcello@icgeb.org.\', \'CNR-IBF, Istituto di Biofisica, Via Celoria 26, I-20133, Milano, Italy; Dipartimento di Bioscienze, Università di Milano, Via Celoria 26, I-20133, Milano, Italy. Electronic address: eloise.mastrangelo@cnr.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-3542(21)00045-010.1016/j.antiviral.2021.105055
?:doi
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 33713730
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
?:title
  • Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all